[The cost-effectiveness of interferon beta treatment in patients with a clinically isolated syndrome in Colombia]. [electronic resource]
- Biomedica : revista del Instituto Nacional de Salud
- 110-7 p. digital
Publication Type: English Abstract; Journal Article; Research Support, Non-U.S. Gov't
2590-7379
10.1590/S0120-41572014000100014 doi
Colombia Cost-Benefit Analysis Decision Trees Demyelinating Diseases--complications Disease Progression Humans Interferon-beta--economics Multiple Sclerosis--etiology Time Factors